Context Therapeutics Inc. (CNTX) vs SCYNEXIS, Inc. (SCYX)
A side-by-side comparison of Context Therapeutics Inc. and SCYNEXIS, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CNTX
Context Therapeutics Inc.
$0.32HealthcareDelayed quote: Oct 6, 2026, 1:54 PM EDT
SCYX
SCYNEXIS, Inc.
$4.89HealthcareDelayed quote: Oct 6, 2026, 1:46 PM EDT
Total return — CNTX vs SCYX
growth of $100 · dividends reinvested · last 5yCNTX -93.4% (-41.9%/yr)SCYX -88.0% (-34.6%/yr)SCYX compounded faster over this window
CNTX SCYX
CNTX vs SCYX: by the numbers
- •SCYX is the larger company ($31M vs $29M market cap).
- •Both run net losses; CNTX's is the smaller (0.00% vs -53.27% net margin).
Metrics side by side
Valuation
| Metric | CNTX | SCYX |
|---|---|---|
| P/S ratio | N/A | 1.60 |
| P/B ratio | 0.77 | 0.46 |
Profitability
| Metric | CNTX | SCYX |
|---|---|---|
| Gross margin | 0.00% | 100.00% |
| Operating margin | 0.00% | -78.03% |
| Net margin | 0.00% | -53.27% |
| ROE | -120.40% | -15.29% |
| ROIC | -126.84% | -32.68% |
Growth (annualized)
| Metric | CNTX | SCYX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 9.78% |
| Total return CAGR (5Y) | N/A | -34.13% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.